Prediction of Active Compounds of Muntingia Calabura as Potential Treatment for Chronic Obstructive Pulmonary Diseases by Network Pharmacology Integrated with Molecular Docking


  • NENDEN NURHASANAH Department of Pharmacology, Faculty of Pharmacy, Universitas Indonesia, Gedung Fakultas Farmasi Kampus UI Depok 16424, Indonesia
  • FADILAH FADILAH Department of Medicinal Chemistry, Faculty of Medicine, Universitas In-donesia, Jl. Salemba Raya no 6, Indonesia
  • ANTON BAHTIAR Department of Pharmacology, Faculty of Pharmacy, Universitas Indonesia, Gedung Fakultas Farmasi Kampus UI Depok 16424, Indonesia



COPD, Molecular docking, Muntingia Calabura, Network Pharmacology, protease inhibitor


Objective: Electronic cigarettes (E-Cigarettes) are often advertised as a safe alternative to smoke cessation. The number of E-Cigarettes users (vapers) has increased in many countries. The health impact of E-Cigarettes research topics still counting constitutes initiating Chronic Obstructive Pulmonary Disease (COPD). This research aimed to analyze the interaction between genes from E-Cigarettes causing COPD with Muntingia Calabura leaves, which has umpteen pharmacological effects through Bioinformatics.

Methods: The related genes in E-Cigarettes compounds underlying COPD conditions were screened and intersected towards M.Calabura's genes target. The constructed networks were analyzed for their protein-protein interaction and pathway possibilities. The gene with the best betweenness centrality, closeness centrality, and degree value was validated using molecular docking methods for its interaction with M.Calabura leaves.

Results: 12 target genes of M.Calabura and COPD were ALB, MMP-9, ICAM-1, GADPH, VEGFA, MPO, AKT1, ELANE, CXCR2, CFRTR, HSPA1A, and ADRB2. MMP-9 had the best value and then became the gene docked with M.Calabura compounds. The signaling propensity probably was PI3K/AKT pathway. M.Calabura has potentiated as a neutrophil inhibitor to balance protease/anti-protease. From molecular docking analyses, we found that 5,7-Dihydroxy-6-methoxyflavone gave the best conformation with MMP-9 with a binding affinity value of -10 kcal/mol.


Download data is not yet available.


National Academies of Sciences. Engineering, and Medicine; Health and Medicine Divi-sion. Public Health Consequences of E-Cigarettes. 2018. DOI: 10.17226/24952.

Center for Disease Control and Prevention. CDC, Smoking & Tobacco Use: Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping, Centers for Disease Control and Prevention, [Online]. No. August 2019, pp. 1–7, 2019 [cited 17 November 2021] Availa-ble:

Kementerian Kesehatan Republik Indonesia. Laporan Nasional Riset Kesehatan Dasar. Kementerian Kesehatan RI. 2018. pp. 1–582,

S. A. Kristina, K. A. Rosyidah, and A. Ahsan. Trend of electronic cigarette use among stu-dents in Indonesia. International Journal of Pharmaceutical Research. 2020; vol. 12, no. 3, pp. 657–661. DOI: 10.31838/ijpr/2020.12.03.099.

J. K. Pepper, K. M. Ribisl, S. L. Emery, and N. T. Brewer, Reasons for starting and stop-ping electronic cigarette use, International Journal of Environmental Research and Public Health. 2014. vol. 11, no. 10, pp. 10345–10361. DOI: 10.3390/ijerph111010345.

I. Garcia-Arcoset al., Chronic electronic cigarette exposure in mice, induce features of COPD in a nicotine-dependent manner, Thorax, vol. 71, no. 12, pp. 1119–1129, 2016, DOI: 10.1136/thoraxjnl-2015-208039.

H. E. O'Farrell et al., E-cigarettes induce toxicity comparable to tobacco cigarettes in air-way epithelium from patients with COPD, Toxicology in Vitro, vol. 75, no. February, p. 105204, 2021, DOI: 10.1016/j.tiv.2021.105204.

S. Gellatlyet al., Nicotine-free e-cigarette vapor exposure stimulates Il6 and mucin produc-tion in human primary small airway epithelial cells, Journal of Inflammation Research, vol. 13, pp. 175–185, 2020, DOI: 10.2147/JIR.S244434.

J. Li et al., Electronic Cigarettes Induce Mitochondrial DNA Damage and Trigger TLR9 (Toll-Like Receptor 9)-Mediated Atherosclerosis, Arteriosclerosis, Thrombosis, and Vas-cular Biology, vol. 9, no. February, pp. 839–853, 2021, DOI: 10.1161/ATVBAHA.120.315556.

C. Herr et al., Cigarette smoke and electronic cigarettes differentially activate bronchial epithelial cells, Respiratory Research, vol. 21, no. 1, pp. 1–13, 2020, DOI: 10.1186/s12931-020-1317-2.

M. A. Song et al., Biomarkers of exposure and effect in the lungs of smokers, nonsmokers, and electronic cigarette users A-C, Cancer Epidemiology Biomarkers and Prevention, vol. 29, no. 2, pp. 443–451, 2020, DOI: 10.1158/1055-9965.EPI-19-1245.

H. Qasimet al., Short-term E-cigarette exposure increases the risk of thrombogenesis and enhances platelet function in mice, Journal of the American Heart Association, vol. 7, no. 15, 2018, DOI: 10.1161/JAHA.118.009264.

R. Rodriguez-Roisin et al., Global Initiative for Chronic Lung A Guide for Health Care Professionals Global Initiative for Chronic Lung, Communications, pp. 1–27, 2009.

T. Kim and J. Kang, Association between dual use of e-cigarette and cigarette and chronic obstructive pulmonary disease: an analysis of a nationwide representative sample from 2013 to 2018, BMC Pulmonary Medicine, vol. 21, no. 1, pp. 1–11, 2021, DOI: 10.1186/s12890-021-01590-8.

M. Hikichi, K. Mizumura, S. Maruoka, and Y. Gon. Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke. 2019. Journal of Thoracic Disease, vol. 11, no. Suppl 17, pp. S2129–S2140. DOI: 10.21037/jtd.2019.10.43.

C. Wang et al. Progress in the mechanism and targeted drug therapy for COPD. Signal Transduction and Targeted Therapy. 2020. vol.5, no.1. DOI: 10.1038/s41392-020-00345-x.

S. Shibata et al. Basophils trigger emphysema development in a murine model of COPD through IL-4–mediated generation of MMP-12–producing macrophages. Proceedings of the National Academy of Sciences of the United States of America. 2018. vol. 115, no. 51, pp. 13057–13062. DOI: 10.1073/pnas.1813927115.

H. Guo-Parke, D. Linden, S. Weldon, J. C. Kidney, and C. C. Taggart. Mechanisms of vi-rus-induced airway immunity dysfunction in the Pathogenesis of COPD disease, progres-sion, and exacerbation. Frontiers in Immunology. 2020, vol. 11, no. June, pp. 1–10. DOI: 10.3389/fimmu.2020.01205.

M. I. M. Yusof, M. Z. Salleh, T. L. Kek, N. Ahmat, N. F. N. Azmin, and Z. A. Zakaria, Activity-guided isolation of bioactive constituents with anti-nociceptive activity from Muntingia Calabura leaves using the formalin test. Hindawi. 2013. pp. 1–27

S. Deering and D. Purnamasari, P. Antiproliferative and apoptosis induction of methanolic extract from Muntingia Calabura leaves on colorectal cancer cell line, Biochemical Phar-macology. 2017. vol. 139, p. 125. DOI: 10.1016/j.bcp.2017.06.002.

J. J. Chen, H. H. Lee, C. Y. Duh, and I. S. Chen. Cytotoxic chalcones and flavonoids from the leaves of Muntingia Calabura. Planta Medica. 2005. vol. 71, no. 10, pp. 970–973, DOI: 10.1055/s-2005-871223.

Ramakrishnan Subhashini, Muthusamy Jeyam. Computational identification of putative drug targets in Malassezia globosa by subtractive genomics and protein cluster network approach. Int J Pharm Pharm Sci. 2017;9(9):215-221.

J. T. Lin, Y. Y. Chang, Y. C. Chen, B. Y. Shen, and D. J. Yang. Molecular mechanisms of the effects of the ethanolic extract of Muntingia Calabura Linn. fruit on lipopolysaccha-ride-induced pro-inflammatory mediators in macrophages. Food and Function. 2017. vol. 8, no. 3, pp. 1245–1253. DOI: 10.1039/c6fo01735e.

W. L. Kuo, H. R. Liao, and J. J. Chen. Biflavans, flavonoids, and a dihydrochalcone from the stem wood of Muntingia Calabura and their inhibitory activities on neutrophil pro-inflammatory responses. Molecules, vol. 19, no. 12, pp. 20521–20535, 2014, DOI: 10.3390/molecules191220521.

M. S. Rofiee et al. Isolating the metabolic pathways involved in the hepatoprotective effect of Muntingia Calabura against CCl4-induced liver injury using LC/MS Q-TOF, Journal of Ethnopharmacology.2015. vol. 166, pp. 109–118. DOI: 10.1016/j.jep.2015.03.016.

S. A. Sari, M. Ernita, M. N. Mara, and M. R. AR, Identification of Active Compounds on Muntingia Calabura.L Leaves using Different Polarity Solvents, Indonesian Journal of Chemical Science and Technology (IJCST).2020. vol. 3, no. 1, p. 1. DOI: 10.24114/ijcst.v3i1.18309.

W. P. C. Buhian, R. O. Rubio, D. L. Valle, and J. J. Martin-Puzon, Bioactive metabolite profiles and anti-microbial activity of ethanolic extracts from Muntingia Calabura L. leaves and stems, Asian Pacific Journal of Tropical Biomedicine. 2016. vol. 6, no. 8, pp. 682–685. DOI: 10.1016/j.apjtb.2016.06.006.

A. N. M. Ansori, V. D. Kharisma, and T. I. Solikhah, Medicinal properties of Muntingia Calabura L.: A review, Research Journal of Pharmacy and Technology. 2021. vol. 14, no. 8, pp. 4509–4512. DOI: 10.52711/0974-360X.2021.00784.

J. Cao et al. A Network Pharmacology Approach to Predict the Proangiogenesis Mechanism of Huangqi-Honghua Herb Pair after Cerebral Ischemia. Evidence-based Complementary and Alternative Medicine. 2021. DOI: 10.1155/2021/9834856.

A. Cunningham, K. McAdam, J. Thissen, and H. Digard. The Evolving E-cigarette: Com-parative Chemical Analyses of E-cigarette Vapor and Cigarette Smoke, Frontiers in Toxi-cology. 2020. DOI: 10.3389/ftox.2020.586674.

M. Li, D. Li, Y. Tang, F. Wu, and J. Wang. Cytocluster: A Cytoscape plugin for cluster analysis and visualization of biological networks. International Journal of Molecular Sciences.2017. vol. 18, no. 9. DOI: 10.3390/ijms18091880.

L. Han et al. Potential mechanism prediction of Cold-Damp Plague Formula against CO-VID-19 via network pharmacology analysis and molecular docking. Chinese Medicine (United Kingdom). 2020. vol. 15, no. 1, pp. 1–16. DOI: 10.1186/s13020-020-00360-8.

H. Berman, K. Henrick, and H. Nakamura. Announcing the worldwide Protein Data Bank, Nature Structural Biology. 2003. vol. 10, no. 12, p. 980. DOI: 10.1038/nsb1203-980.

H. Li, A. Hung, and A. W. H. Yang. Herb-target virtual Screening and network pharma-cology for prediction of the molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer. Scientific Reports. 2021. vol. 11, no. 1, pp. 1–15. DOI: 10.1038/s41598-021-86141-1.

O. Trott and A. J. Olson. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, Journal of Com-putational Chemistry. 2009. vol. 31, no. 2. DOI: 10.1002/jcc.21334.

K. J. Gou et al. Anti-rheumatoid arthritis effects in adjuvant-induced arthritis in rats and molecular docking studies of Polygonum orientale L. extracts. Immunology Letters. 2018. vol. 201, no. September, pp. 59–69. DOI: 10.1016/j.imlet.2018.11.009.

J. Liu et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of HuaiHua san against ulcerative coli-tis, Drug Design, Development and Therapy 2021. vol. 15, no. July, pp. 3255–3276. DOI: 10.2147/DDDT.S319786.

J. J. Chen, H. H. Lee, C. D. Shin, C. H. Liao, I. S. Chen, and T. H. Chou, New dihydro-chalcones and antiplatelet aggregation constituents from the leaves of Muntingia Calabura, Planta Medica. 2007. vol. 73, no. 6, pp. 572–577. DOI: 10.1055/s-2007-967196.

A. S. Sufian, K. Ramasamy, N. Ahmat, Z. A. Zakaria, and M. I. M. Yusof, Isolation and identification of antibacterial and cytotoxic compounds from the leaves of Muntingia Ca-labura. Journal of Ethnopharmacology, 2013. vol. 146, no. 1, pp. 198–204. DOI: 10.1016/j.jep.2012.12.032.

N. Jisha, A. Vysakh, V. Vijeesh, and M. S. Latha, Ethyl acetate fraction of Muntingia Ca-labura exerts anti-colorectal cancer potential via regulating apoptotic and inflammatory pathways, Journal of Ethnopharmacology, 2020. vol. 261, no. May, p. 113064. DOI: 10.1016/j.jep.2020.113064.

H. R. Liao, J. J. Chen, Y. H. Chien, S. Z. Lin, S. Lin, and C. P. Tseng, 5-hydroxy-7-methoxyflavone inhibits N-formyl-l-methionyl-l-leucyl-l- phenylalanine-induced superoxide anion production by specific modulate membrane localization of Tec with a PI3K in-dependent mechanism in human neutrophils, Biochemical Pharmacology. 2012. vol. 84, no. 2, pp. 182–191. DOI: 10.1016/j.bcp.2012.03.015.

B. N. Suet al. Activity-guided isolation of the chemical constituents of Muntingia Calabura using a quinone reductase induction assay. Phytochemistry. 2003. vol. 63, no. 3, pp. 335–341. DOI: 10.1016/S0031-9422(03)00112-2.

J. Nair, M. Ghatge, V. v. Kakkar, and J. Shanker. Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease. PLoS ONE. 2014. vol. 9, no. 4. DOI: 10.1371/journal.pone.0094328.

C. Wang et al., progress in the mechanism and targeted drug therapy for COPD. Signal Transduction and Targeted Therapy. 2020. vol. 5, no. 1. DOI: 10.1038/s41392-020-00345.

H. Ilumets et al. Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD International Journal of COPD. 2007. vol. 2, no. 3, pp. 369–379. DOI: 10.2147/COPD.S.

J. T. Benjamin et al. Neutrophilic inflammation during lung development disrupts elastin assembly and predisposes adult mice to COPD. Journal of Clinical Investigation. 2021. vol. 131, no. 1. DOI: 10.1172/JCI139481.

A. Churg, S. Zhou, and J. L. Wright. Matrix metalloproteinases in COPD. European Respi-ratory Journal. 2012. vol. 39, no. 1, pp. 197–209. DOI: 10.1183/09031936.00121611.

Kuswandi A, Rusdin, Tarawan VM, Goenawan H, Lesmana R, Muchtaridi M. Molecular docking study of the major compounds from Garcinia Atrovirdis on human SGLT-2 Pro-tein Transport Using Structure-Based Drug Design Method. Int J App Pharm, Vol 14, Issue 4, 2022, 138-143. DOI: 10.22159/ijap.2022v14i4.44390.



How to Cite

NURHASANAH, N., FADILAH, F., & BAHTIAR, A. (2022). Prediction of Active Compounds of Muntingia Calabura as Potential Treatment for Chronic Obstructive Pulmonary Diseases by Network Pharmacology Integrated with Molecular Docking. International Journal of Applied Pharmaceutics, 15(1).



Original Article(s)